<!DOCTYPE html>
<html lang="en-US"><head>
		<meta charset="UTF-8">
		<title>FT944-13990</title>
	</head>
	<body>
		<main>
			<p>941025 FT  25 OCT 94 / International Company News: Pfizer claims success for arthritis drug The first significant successes in slowing the progression of rheumatoid arthritis were claimed yesterday by Pfizer, the US drugs group, writes Richard Waters. The company said that clinical tests of Enablex, a drug currently awaiting approval from the US Food and Drug Administration, showed it had achieved 'a statistically significant decrease' in the rate of joint deterioration in patients. Full results of the trial will be presented at the annual meeting of the American College of Rheumatology this week.</p>
		</main>
</body></html>
            